🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/03/2004 | 66,10 | 68,31 | 65,58 | 66,59 | +2,24% | 4,13% | 381.354 |
| 11/03/2004 | 66,89 | 68,31 | 64,87 | 65,13 | -1,97% | 5,15% | 318.222 |
| 10/03/2004 | 68,12 | 69,25 | 65,54 | 66,44 | -2,31% | 5,44% | 304.650 |
| 09/03/2004 | 69,43 | 70,48 | 67,56 | 68,01 | -1,78% | 4,20% | 364.308 |
| 08/03/2004 | 72,05 | 72,91 | 68,31 | 69,25 | -5,08% | 6,39% | 690.305 |
| 05/03/2004 | 70,22 | 74,82 | 70,18 | 72,95 | +0,88% | 6,61% | 734.762 |
| 04/03/2004 | 68,46 | 74,86 | 68,35 | 72,31 | +5,63% | 9,51% | 1.262.469 |
| 03/03/2004 | 69,99 | 70,74 | 65,80 | 68,46 | +12,97% | 7,06% | 3.891.737 |
| 02/03/2004 | 60,26 | 64,19 | 60,11 | 60,60 | +3,58% | 6,77% | 1.176.736 |
| 01/03/2004 | 57,90 | 59,96 | 57,45 | 58,50 | +1,56% | 4,33% | 258.163 |
| 27/02/2004 | 58,62 | 59,10 | 57,45 | 57,60 | -1,54% | 2,81% | 284.693 |
| 26/02/2004 | 58,88 | 58,95 | 57,12 | 58,50 | -0,95% | 3,12% | 262.251 |
| 25/02/2004 | 56,71 | 59,14 | 56,52 | 59,06 | +4,78% | 4,62% | 271.094 |
| 24/02/2004 | 57,64 | 57,72 | 54,50 | 56,37 | -1,57% | 5,58% | 415.337 |
| 23/02/2004 | 59,85 | 59,89 | 56,26 | 57,27 | -3,29% | 6,07% | 226.958 |
| 20/02/2004 | 60,56 | 60,56 | 57,94 | 59,21 | -2,10% | 4,33% | 225.756 |
| 19/02/2004 | 60,82 | 62,21 | 59,85 | 60,49 | -0,43% | 3,88% | 513.735 |
| 18/02/2004 | 60,60 | 63,41 | 59,89 | 60,75 | +1,56% | 5,81% | 455.546 |
| 17/02/2004 | 59,03 | 59,81 | 58,50 | 59,81 | +2,50% | 2,22% | 281.353 |
| 13/02/2004 | 59,63 | 60,49 | 58,13 | 58,35 | -2,20% | 3,95% | 239.488 |
| 12/02/2004 | 61,20 | 61,46 | 58,99 | 59,66 | -1,85% | 4,04% | 499.602 |
| 11/02/2004 | 57,64 | 61,76 | 57,08 | 60,79 | +8,27% | 8,12% | 1.236.741 |
| 10/02/2004 | 54,42 | 56,22 | 54,16 | 56,14 | +4,38% | 3,78% | 573.634 |
| 09/02/2004 | 55,77 | 56,22 | 53,26 | 53,79 | +0,07% | 5,30% | 634.815 |
| 06/02/2004 | 52,10 | 54,20 | 51,73 | 53,75 | +3,91% | 4,74% | 266.098 |
| 05/02/2004 | 53,34 | 55,02 | 50,94 | 51,73 | -3,22% | 7,65% | 325.275 |
| 04/02/2004 | 55,06 | 55,06 | 52,78 | 53,45 | -2,92% | 4,15% | 141.411 |
| 03/02/2004 | 55,77 | 55,92 | 53,94 | 55,06 | +1,31% | 3,56% | 182.448 |
| 02/02/2004 | 53,49 | 55,28 | 52,48 | 54,35 | +0,90% | 5,25% | 144.671 |
| 30/01/2004 | 53,97 | 55,13 | 52,44 | 53,86 | +0,00% | 4,99% | 117.794 |